The Lockwood Group (Lockwood), a medical communications agency, has been recognized by Inc. magazine in their 2017 Inc. 5000 annual ranking of the fastest-growing private companies in America. This prestigious list of the nation's most successful private companies has become the hallmark of entrepreneurial success and the place where future household names first make their mark. Lockwood propelled to the top half of the list of 5000, ranked #2,208 nationally, and #12 in the state of Connecticut!
The agency, led by President and Chief Executive Officer Matthew Schecter, is extremely proud of this distinction, which measures the company's growth over the last three years specifically. "This recognition is a testament to the hard work that the team at Lockwood puts in for our customers on a daily basis. To be able to grow an organization 165% over the last three years is no small feat and requires a scalable infrastructure, which is critical to Lockwood's success. I am so proud of all that we have accomplished in such a short time and excited about what we still have left to do!" said Schecter.
Lockwood collaborates with clients in the pharmaceutical, biotech, genetic, and medical device industries to identify effective, holistic, science-based strategies to address their objectives through medical communications. Over a third of Lockwood's staff hold advanced scientific or medical degrees, and most work from where they live. This flexible structure provides better work-life balance, which in turn allows Lockwood to attract the best talent who facilitate their best work, and are more responsive to client needs wherever and whenever they do business.
"We say we are committed to exceeding the expectations of our clients, and we demonstrate it by growing our business and staffing our teams large enough to over-deliver on our promises," says Debbie Joyce, Group Vice President of Client Services.
"There is no other agency in our industry who can provide the level of scientific expertise that Lockwood has. We have more than 50 full-time scientists on staff who can not only analyze the data, but can translate them into a clinically compelling story for our clients," said Ramana Yalamanchili, PhD, MBA, Group Vice President, Scientific Services.
While growth may be daunting to some, and may ultimately lead to the demise of some agencies that are unprepared to keep up the pace, Lockwood embraces growth as a chance to provide extraordinary opportunities to team members. Whether developing the strategy that helps healthcare providers understand how to use cutting-edge oncology immunotherapy, traveling to support client business in over 35 countries, meeting patients who help raise awareness of a rare disease, or engaging payers to help support optimal coverage and access, Lockwood team members thrive on the opportunity to do new and different things every day.
Timothy Bayley, DO, PhD, a Senior Scientific Director at Lockwood, says it best: "I don't always know what my day will look like at Lockwood, but I do know that it will be interesting, exciting, and I'll be working alongside really great teammates."
About Lockwood www.thelockwoodgrp.com (http://www.thelockwoodgrp.com/ )
Founded in 2007 and headquartered in Stamford, Connecticut, Lockwood communicates clinical and therapeutic advances to every variety of medical expert, healthcare practitioner, and decision maker. For the ultimate benefit of patients, Lockwood helps clients advance their objectives in a world of new regulations, business models, payment approaches, technologies, roles, and work practices. Lockwood teams are organized around the specific needs of each client. With experience in all major therapeutic areas and many rare diseases, along with highly specialized knowledge in biologics, devices, and diagnostics, Lockwood can quickly deploy the right scientific, business, and communications experts to address the challenges at hand. Take a tour of the Lockwood offices here: https://goo.gl/QcKAL3.
